Valuation: Getinge AB

Market Cap 56.27B 5.84B 5.11B 4.71B 4.33B 8.21B 562B 8.35B 22.08B 275B 21.95B 21.47B 947B P/E 2026 *
19.7x
P/E 2027 * 16.9x
Enterprise Value 64.87B 6.74B 5.89B 5.43B 5B 9.46B 648B 9.63B 25.45B 317B 25.3B 24.75B 1,092B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.71x
Free-Float
78.61%
Yield 2026 *
2.45%
Yield 2027 * 2.68%
1 day-1.62%
1 week+1.53%
Current month+4.35%
1 month+2.03%
3 months+3.16%
6 months-11.14%
Current year-6.94%
1 week 18.3
Extreme 18.3
18.92
1 month 17.28
Extreme 17.275
18.92
Current year 16.36
Extreme 16.355
21.11
1 year 16.36
Extreme 16.355
21.11
3 years 14.23
Extreme 14.23
21.11
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO - 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%+1.53% - - 5.85B
+0.15%-0.17%+33.97%+0.57% 12.44B
+0.84%-4.85%+53.95%+26.94% 5.96B
+2.53%+2.66% - - 4.22B
+4.41%+12.81%-27.65%+20.94% 4.25B
+2.12%+6.89%-20.49%-22.62% 3.96B
-1.72%-2.17%-3.23%+245.39% 1.89B
+3.09%-7.71%-4.53%-59.86% 1.8B
-0.82%-0.82%+56.44%-3.65% 1.54B
+2.33%+2.05%-15.70%-45.05% 1.29B
Average +1.13%+1.07%+9.10%+20.33% 4.15B
Weighted average by Cap. +0.91%+1.29%+18.05%+13.83%

Financials

2026 *2027 *
Net sales 35.01B 3.64B 3.18B 2.93B 2.7B 5.11B 350B 5.19B 13.74B 171B 13.65B 13.35B 589B 36.81B 3.82B 3.34B 3.08B 2.83B 5.37B 368B 5.46B 14.44B 180B 14.36B 14.04B 620B
Net income 2.85B 296M 259M 239M 220M 416M 28.49B 423M 1.12B 13.93B 1.11B 1.09B 48B 3.3B 342M 299M 276M 254M 481M 32.95B 489M 1.29B 16.1B 1.29B 1.26B 55.5B
Net Debt 8.6B 893M 781M 720M 662M 1.25B 85.94B 1.28B 3.37B 42B 3.35B 3.28B 145B 6.62B 687M 601M 554M 510M 965M 66.13B 982M 2.6B 32.32B 2.58B 2.52B 111B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,754
Date Price Change
26-07-15 €18.58 -1.62%
26-07-14 €18.89 0.00%
26-07-13 €18.89 +3.20%
26-07-10 €18.30 +0.77%
26-07-09 €18.16 -0.77%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
206.60SEK
Average target price
226.70SEK
Spread / Average Target
+9.73%

Quarterly revenue - Rate of surprise